Alexander Green’s Next Magnificent Seven

Alexander Green’s “next Magnificent Seven” is the implied promise in his “OXF Retire” campaign: the man who “found Apple in 1996, Netflix and Amazon in 2005, Nvidia in 2004” says the current moment will mint the next generation of category-defining stocks, and his Oxford Communiqué is where he says he will name them. If you searched the framing, here is what the pitch actually claims, what verifies, and our honest read of the track record and the promise. The complete treatment is our OXF Retire review.

The Track Record, Which Verifies

Green is the Chief Investment Strategist of The Oxford Club, and his track-record block is unusually well specified: “he’s the man who found Apple in 1996, Netflix and Amazon in 2005, Nvidia in 2004.” The presentation quotes his actual 2004 Nvidia recommendation verbatim, “outselling chips so powerful that current hardware and gaming software can’t even exploit that technology yet,” and his Intuitive Surgical call from the same year, “It holds a monopoly position in surgical robots.” The personal detail that lands hardest: “the weird thing, Chris, is i still own every share.”

The named picks are real and check out at their stated orders of magnitude: Nvidia’s split-adjusted 2004 price was pennies; Intuitive Surgical is up roughly 20,000% since 2004; Palantir was the best-performing S&P 500 stock of 2024. His book The American Dream is a genuine #1 Amazon-bestselling title.

The caveats our review attaches: the selection is survivor-heavy (the transcript concedes “some, quite frankly, Don’t work out at all”), and the track record has no losing picks displayed, which is the standard asymmetry of the genre; the credibility of the wins does not transfer automatically to the unnamed current picks.

What the Campaign Promises Next

The OXF Retire pitch’s vehicle is the ASI Fund framing: “a private Federal Reserve for the AI industry,” buyable “around $15,” plus three bonus picks with fingerprints (the AI Superstock with the “$15.9 billion over five years” OpenAI deal and “36,000% growth in three years”; the cobot company with “80,000 advanced robotic systems” and “34% of the cobot market”; the SMR name with “400 mini reactors for the US Navy”). All four sit behind the $99 trial, unnamed.

The macro frame around the picks: “President Trump’s unleashing what Alex is calling a $216 trillion AI event… at least $216 trillion in new wealth for the United States and that’s nearly five times the national debt,” a figure the host himself challenges three separate times (“that number seems ridiculously impossible”), and which Green sources to long-term ASI projections (Cathie Wood’s $200 trillion estimate, an NBER paper) rather than a market forecast.

The Honest Read

The Magnificent Seven framing is really a question about process: can the picker repeat? The honest answer from the evidence: Green’s documented calls show a real talent for identifying category-defining businesses early, the current campaign’s picks are unnamed fingerprints, and the bridge between the two is the subscription, with a 365-day full-refund guarantee making the trial of his current research nearly costless to evaluate.

What we would hold at arm’s length: the $216 trillion frame (marketing arithmetic on top of genuine build-out facts), the “risk-free” phrasing ($99 is at risk pending refund), the Trump-income framing in the cold open (the promo’s characterization of public reporting, not verifiable from the transcript, and described here only factually and neutrally as the pitch’s hook), and the testimonials, which appear without compensation disclosure.

For the process’s layers: our Alexander Green profile from the original campaign, the Oxford Communiqué review covering the letter itself, and the original ASI Fund review as the definitive treatment of the campaign’s spine.

Frequently Asked Questions

What are Green’s documented calls? The pitch’s block: “he’s the man who found Apple in 1996, Netflix and Amazon in 2005, Nvidia in 2004,” with his 2004 Nvidia recommendation quoted verbatim (“outselling chips so powerful that current hardware and gaming software can’t even exploit that technology yet”) and his Intuitive Surgical call from the same year (“It holds a monopoly position in surgical robots”). The named picks check out at their stated orders of magnitude: Nvidia’s split-adjusted 2004 price was pennies; Intuitive Surgical is up roughly 20,000% since; Palantir was the best-performing S&P 500 stock of 2024.

Does he show his losers? The transcript concedes “some, quite frankly, Don’t work out at all,” but no losing picks are displayed, which is the standard survivor-heavy asymmetry of the genre. The credibility of the wins does not transfer automatically to the unnamed current picks.

What is he pitching now? The ASI Fund framing (“a private Federal Reserve for the AI industry,” buyable “around $15”) plus three fingerprinted bonus reports: the AI Superstock (a “$15.9 billion over five years” OpenAI deal, “36,000% growth in three years”), the cobot company (“80,000 advanced robotic systems,” “34% of the cobot market”), and the SMR name (“400 mini reactors for the US Navy”). All four are unnamed behind the $99 trial.

What does this mean? The Magnificent Seven framing is a process question (can the picker repeat?), and the honest evidence is: documented early-identification talent, survivor-only display, and a 365-day full-refund guarantee that makes evaluating his current research nearly costless. Use the year.

The Offer

The trial membership: The Oxford Communiqué monthly with “Alex’s top stock recommendation each month,” the four research reports, The American Dream hardback, the Millionaire-Maker video series, the model portfolio with weekly updates, and Clubroom access with weekly live sessions, at “normally membership is only $249, but… today, i’m offering a risk-free trial for just $99,” with a further discount behind the order-form button and the 365-day, 100% money-back guarantee keeping everything received. The full presentation is here.

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.